AZD4831

Mitiperstat (AZD4831) is the potent inhibitor of myeloperoxidase (MPO). Mitiperstat is particularly useful in the research of prophylaxis of cardiovascular disorders such as heart failure and coronary artery disease related conditions (extracted from patent US20160152623A1).


Cat. No.: EX-A7129	Purity: >98%

	Chemical structure of AZD4831

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	450	In-stock
50mg	550	In-stock
100mg	700	In-stock
250mg	1200	In-stock
500mg	1900	In-stock
1g	3120	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	Mitiperstat
Synonyms 2	AZD-4831
CAS No.	1933460-19-5
Purity	>98%
Formula	C15H15ClN4OS
Mol Weight	334.824
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Tord Bertil INGHARDT, et al. 1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES AS INHIBITORS OF MYELOPEROXIDASE. Patent US20160152623A1. [2]. Lam, Carolyn S P et al. “Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results.” Journal of cardiac failure vol. 30,1 (2024): 104-110. doi:10.1016/j.cardfail.2023.04.003 [3]. Bhattacharya, Chandrali et al. “Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans.” Drug metabolism and disposition: the biological fate of chemicals vol. 51,4 (2023): 451-463. doi:10.1124/dmd.122.001100
Data Sheet	Data sheet of AZD4831
CoA	CoA of AZD4831
SDS	SDS of AZD4831


		Search